In the field of cephalosporins, the antibacterial activity strongly depends on the acyl moiety at the 7-position. Among a number of potent cephalosporins produced during the past twenty years, the aminothiazolyl oxyimino series such as ceftizoxime", cefotaxime','', cefinenoxime°' and ceftriaxones'
in particular have not only excellent antibacterial properties but also marked resistance to ,3-lactamases.
One of the common structural characteristics of these compounds is the amino function on the thiazole ring, and it would seem that this amino function is important for potent antibacterial activities.
Our effort was concentrated on elucidating the effect of the amino function on the aromatic ring and finding a new acyl moiety superior to the aminothiazole derivatives.
The alternation of the heteroaromatic ring possessing an amino function has not been extensively studied in the past. We succeeded in synthesizing 2-amino-6-pyridyl-, 2-amino-5-pyridyl-, 2-amino-4-pyridyland 4-amino-2-pyridylacetic acids possessing an oxime group in the a-position, all of which were new compounds.
The antibacterial activities of their cephalosporin derivatives were examined as a function of the MIC values.
In this paper, we report the preparation of aminopyridyl side chain acids, the new antibiotics and the result of the structure-activity studies". 
Chemistry
The side chain 2-(2-formamidopyridin-6-yl)-2-alkoxyiminoacetic acids were prepared by the two methods outlined in Scheme 2. According to Method A, aminopicoline (I) was converted to III via the disilylated compound (II), which was obtained by reaction with n-butyllithium and trimethylsilyl chloride (TMSCI). Attempts to carboxylate the N-acyl, phthaloyl or monosilylated derivatives of I were not successful. III was protected by formylation with a mixture of formic acid and acetic anhydride and oxidized with SeO.. to afford the keto ester (IV), which was hydrolyzed with sodium hydroxide in 80 % aqueous ethanol and then converted to the desired compound (V) by reaction with an appro- priate oxyamine RONH2
In addition, we developed an improved method which avoids the use of large amounts of n-butyllithium for a large scale preparations. According to Method B, methyl 2-formamidopyridyl-6-carboxylate (VII), obtained by N-protection of VI, was transformed to VIII by reaction with sodium hydride and methyl methylthiomethyl sulfoxide according to the OGURA method7). VIII was converted to the corresponding ketothioester (IX) by heating with sodium periodate in glacial acetic acid. In this rearrangement, without sodium periodate, a significant amount of X was obtained. This product (X) might have been generated from the intermediate (Xa) through addition of the methanethiol arising from the reaction.
To transform the orthothioformate (X) into the ketothioester (IX), the reagent (Nato,) was throughly effective, without any unfavored side reaction. However other known oxidizing reagents such as hydrogen peroxide, periodic acid and m-chloroperbenzoic acid were not effective. Compound IX thus obtained was converted to the desired compound (V) by hydrolysis and subsequent reaction with an appropriate oxyamine RONH.,.
2-(2-Formamidopyridin-5-yl)-2-methoxyiminoacetic acid, 2-(2-formamidopyridin-4-yl)-2-methoxyiminoacetic acid and 2-(4-formamidopyridin-2-yl)-2-methoxyiminoacetic acid were obtained in a manner similar to that of Method B. However in the case of these compounds, a mixture of acetic anhydride and formic acid (volume ratio: approximately 1 : 10) was used to convert VIII to the ketothioester (IX), because these formyl groups were very easily lost by heating in acetic acid.
The hydroxyiminoacetic acid (Va) was converted to the corresponding dichloroacetoxyimino compound (XI) by treating with dichloroacetyl chloride in order to protect the hydroxyl group. The dichloroacetoxy group was smoothly removed by treating with aqueous NaHCO3
Monochloro and dichloro aminopyridine derivatives were prepared by chlorination of the N-deprotected compound (XII) of V (Scheme 3).
The cephalosporins were prepared either by coupling the 2-formamidopyridyl-2-alkoxyiminoacetic acid with 7,;-aminoceph-3-em-4-carboxylic acids possessing various substituents at the 3-position or by displacing the 3-acetoxy group with thiol compounds after acylation of 7,3-aminocephalosporanic acid.
The acylated cephalosporins were deformylated by treatment with concentrated hydrochloric acid in methanol.
Antibacterial Activity methyl group which is typical in this field4,8).
In the 2-aminopyridine series (compounds 1, 2 and 3), the activity of compound 1 is significantly higher than the other two (2 and 3) against all organisms except Staphylococcus aureus. On the other hand, a shift of the amino function in the 4-aminopyridin-2-yl derivative (4) showed considerable activity, but which was still lower than that of 1, especially against Pseudomonas aeruginosa.
These results suggest that the positions of the amino function and oxyiminoacetic moiety were very important for good antibacterial activities. Therefore we assumed that the partial structure shown in Scheme 4 might be necessary for good activities. Interestingly the partial structure is consist with the aminothiazolyloxyiminocephalosporins.
The successful synthesis of 2-aminopyridin-6-ylcephalosporin derivatives which exhibited potency comparable to that of ceftizoxime prompted us to make further chemical modifications.
The monochlorinated derivative (5) had poor activity against Gram-negative bacteria except Proteus vulgaris and the dichlorinated compound (6) was generally inactive against Gram-negative bacteria but exhibited higher activity than compound 5 against S. aureus.
Exchanging the alkoxyimino part led to no significant change of activity except that the hydroxyimino derivative (7) improved the activity against S. aureus and E. coli, but poorer activity against P. Table 3 . Antibacterial activity (MIC ug/ml) of 2-aminopyridin-6-ylcephalosporins. (Table 2) . As a result of our investigations, we have succeeded in finding a new acyl moiety which confers potent antibacterial activities, and have demonstrated experimentally that the partial structure shown in Scheme 4 is associated with potent antibacterial activities.
Experimental
Melting points were determined using a Thomas-Hoover capillary melting point apparatus and are uncorrected. IR spectra were taken on a Hitachi 260-10 spectrophotometer or Shimadzu IR-420 spectrophotometer.
NMR spectra were recorded at 60 MHz on a JNM-PMX 60 NMR spectrometer and at 100 MHz on a Jeol-MH 100 NMR spectrometer using TMS as an internal standard. The following abbreviations are used: s singlet, d doublet, dd double doublet, t triplet,uartet, m multiplet, ABq AB quartet, bs broad singlet. Organic solvents were dried over anhydrous MgSO4 and all concentrations by evaporation were carried out in vacuo.
Determination of In Vitro Antibacterial Activity All the in vitro antibacterial activities are given as MIC in leg/ml required to prevent growth of the bacterial culture. MIC's were determined by the agar dilution method using heart infusion agar (Difco) after incubation at 37°C for 20 hours with an inoculum size of about l06cfu/ml.
General Preparation of V Method A: 1) 2-[N,N-Bis(trimethylsilyl)amino]-6-methylpyridine (II):
A 15 % n-hexane solution (636 g) of n-butyllithium was added to a solution of 1(64.8 g) in tetrahydrofuran (500 ml) at -20 to -30°C over 1 hour, and stirred at -8 to -10°C for 30 minutes. To the solution was added trimethylsilylchloride (161.7 g) at -15 to -5°C over 40 minutes, and the resultant solution was stirred at room temperature overnight. The solution was filtered through by a column packed with silica gel (180 g), washed with tetrahydrofuran and then the filtrate was concentrated. The residue was purified by fractional distillation to give II (127.6 g, 84.4 %) ; by 95 -97"C/5 -6 mmHg.
2) Ethyl 2-(2-Aminopyridin-6-yl)acetate (III): A 15 % n-hexane solution (338.6 g) of n-butyllithium was added dropwise to a solution of II (100 g) in anhydrous THE (300 ml) at -20 to -30'C over 1 hour, then the solution was stirred at 20 to 23°C for 1 hour. The resultant solution was added in small portions to crushed dry ice (1 kg) with stirring, and stirring was continued until room temperature was reached. After removing tetrahydrofuran from the solution in vacuo, absolute ethanol (1 liter) was added to the residue. An anhydrous 30% ethanol solution (660 ml) of hydrochloric acid was added dropwise to the solution at -5 to -10°C and further hydrogen chloride gas was bubbled at 0 to 5°C for 30 minutes, then the solution was stirred at 10°C overnight. After removing the ethanol, the residue was dissolved in water, and washed with ethyl acetate 3 times. The solution was adjusted to pH 7 to 8 with sodium bicarbonate and extracted with ethyl acetate. The extract was dried and concentrated to give the crude product (54g, 75.0%). The product was purified by column chromatography on silica gel (1 kg) (eluant; EtOAc-CBHe, 3: 1) to give 111 (30.2 g, 41.9%); mp 66-68°C.
Anal Calcd for C9H12N2O2: C 59.98, H 6.71, N 15.55. Found: C 59.77, H 6.50, N 15.21. 3) Ethyl 2-(2-Formamidopyridin-6-yl)glyoxylate (IV): Acetic anhydride (16.6 ml) and 98 formic acid (7.32 ml) were mixed at room temperature and stirred at 50 to 60°C for 30 minutes. The solution was added dropwise to a solution of III (26.5 g) in ethyl acetate (250 ml) at 20 to 23°C over 30 minutes, and stirred at the same temperature for 1 hour. Cold water was added to the resultant solution and the mixture was shaken thoroughly. The ethyl acetate layer was separated, washed with water, aqueous sodium bicarbonate and water in turn, dried and concentrated to give ethyl 2-(2-formamidopyridin-6-yl)acetate (28 g, 91.5 %); mp 35 -38°C: IR (Nujol) 3250, 3100, 1738, 1690, 1580, 1460, 1305, 1277 cm-I. To a solution of the above compound (26 g) in dioxane (260 ml) was added selenium dioxide (16.65 g) in small portions at 85 to 90°C over 1 hour and stirred at the same temperature for 1 hour. After cooling the resultant mixture, the dioxane layer was separated, concentrated and residue was dissolved in ethyl acetate. The solution was washed with water, and treated with activated charcoal and then concentrated to give IV (14.3 g, 51.5%); mp 124-126°C; IR (Nujol) 3220, 3100, 1737, 1720, 1690, 1273, 1233 cm-1.
4) 2-(2-Formamidopyridin-6-yl)-2-methoxyiminoacetic Acid (Vb, Z isomer): 2 N Sodium hydroxide solution in 80% aqueous ethanol (14.9 ml) was added to a solution of IV (6.0 g) in ethanol (180 ml) at room temperature and stirred at that temperature for 20 minutes. Methoxyamine hydrochloride (2.7 g) was added to the resultant solution, stirred at room temperature for 1.5 hours and then concentrated to a small volume. The precipitates were collected by filtration, washed with ethyl acetate and water, dissolved in methanol and then treated with activated charcoal. The solution was concentrated and then the precipitates were collected by filtration to give Vb (Z isomer) (3.6 g, 60.2%), which was recrystallized from EtOAc -Et.O; mp 170-171'C (dec).
Anal Calcd for COHON3O4: C 48.43, H 4.06, N 18.83. Found: C 48.79, H 4.28, N 18.84. The configuration of the oxyimino group of Vb and the following side chain acids must be Z form since in these cephalosporin derivatives, the NMR chemical shift of the amide proton at the C-7 position was observed at very low field as same as that of aminothiazolyl cephems'•0'.
Method B: 1) Methyl 2-Formamido-6-pyridinecarboxylate (VII): A mixture of formic acid (559.3 g) and acetic anhydride (1,033.4 g) was stirred for 30 minutes at 40 to 50°C and thereto was added VI10) (616 g) at 40'C, and then the mixture was stirred for 1 hour at 80'C. After the removal of the solvent from the reaction mixture, to the residue was added a mixture of benzene (2 liters) and n-hexane (6 liters). The precipitates were collected by filtration and then recrystallized from benzene (2 liters) to give VII (647.8 g, 88.8%); mp 134-136°C.
Anal Calcd for C5HbN_O3: C 53.33, H 4.48, N 15.55. Found : C 53.37, H 4.40, N 15.58. 2) 2-Formamido-6-(2-methanesulfinyl-2-methylthioacetyl)pyridine (VIII): To a mixture of VII (435.7 g), methyl methylthiomethyl sulfoxide (300 g) and N,N-dimethylformamide (2.2 liters) was added portionwise 50 % oil suspension sodium hydride (348 g) with stirring and ice cooling, and the mixture was stirred for 30 minutes at room temperature.
To the reaction mixture was added methylene chloride (4.4 liters) with ice cooling, the precipitates were collected by filtration and then added to a mixture of methylene chloride (3 liters), ice (2 kg) and concentrated hydrochloric acid (730 ml). The mixture was adjusted to pH 7 with sodium bicarbonate and extracted with methylene chloride. The extract was dried, concentrated and crystallized from diethyl ether to give VIII (430 g, 65. 4) 2-(2-Formamidopyridin-6-yl)-2-ethoxyiminoacetic Acid (Vc, Z isomer): A mixture of IX (4.5 g), methanol (20 ml) and 1 N aqueous sodium hydroxide (20 ml) was stirred for 50 minutes at room temperature to give a solution containing 2-(6-formamidopyridin-2-yl)glyoxylic acid. To the solution was added O-ethylhydroxylamine hydrochloride (2.2 g), and the mixture was stirred for 35 minutes at that temperature. The reaction mixture was adjusted to pH 7 with hydrochloric acid and the methanol was distilled off. The remaining aqueous mixture was washed with ethyl acetate, then layered with ethyl acetate and adjusted to pH 1 with 10% hydrochloric acid. The ethyl acetate layer was separated, washed with water, treated with activated charcoal and then concentrated to give Vc (Z isomer) (2.3 g, 48.0%), which was recrystallized from EtOAc -Et_O; mp 183 -184-C (dec).
Anal Calcd for C10H11N O,: C 50.63, H 4.67, N 17.72. Found: C 50.21, H 4.89, N 17.35. 2-Aminopyridin-5-yl, 2-aminopyridin-4-yl, 4-aminopyridin-2-yl derivatives were obtained respectively from 2-amino-5-pyridinecarboxylatel1~, 2-amino-4-pyridinecarboxylatel" ), 4-amino-2-pyridinecarboxylate13) according to Method B. The properties of these compounds are listed in Table 4 . 2-(2-Formamidopyridin-6-yl)acetic acids derivatives bearing various oxime substituents which were obtained by the reaction with the corresponding alkoxyamine are listed in Table 5 .
2-(2-Formamidopyridin-6-yl)-2-dichloroacetoxyiminoacetic
Acid (XI, Z isomer) A mixture of Va (3.6 g), dichloroacetyl chloride (7.6 g) and methylene chloride (100 m]) was stirred at room temperature for 5 hours. The precipitates were collected by filtration, washed with diethyl ether and dried to give XI (4.6 g, 83.6%); mp 88'90-C; IR (Nujol) 1800, 1720, 1620 cm-1.
Preparation of the Monochloro and Dichloro Derivatives (XIII, XIV, Z isomer) A mixture of Vb (Z isomer) (5.0 g) and concentrated hydrochloric acid (2.3 ml) in methanol (50 ml) was stirred for 40 minutes at room temperature.
After the removal of methanol from the reaction mixture, the residue was pulverized in diethyl ether, collected by filtration to give 2-(2-aminopyridin-6-yl)-2-methoxyiminoacetic acid hydrochloride (XII) (Z isomer) ( To a mixture of XII (8.0 g), acetic acid (350 nil) and water (10 ml) was introduced chlorine gas for 1 hour at S -C. After the removal of excess chlorine gas by bubbling air into the reaction mixture, the solvent was distilled off. The residue was pulverized in diethyl ether and collected by filtration. After the addition of water and ethyl acetate to the resultant powder (9.8 g), the aqueous layer was separated and washed with ethyl acetate twice and then the water was distilled off. The remaining water in the residue was azeotropically removed with benzene twice to yield a brownish powder, which was dried in a desiccator to give 2-(2-amino-5-chloropyridin-6-yl)-2-methoxyiminoacetic acid (XIII) (Z isomer) (3. . Separately, the 7-aminocephem derivative (5 mmol) and trimethylsilylacetamide (7.2 g) were dissolved in methylene chloride (20 ml) at 40°C and cooled. To the cool solution was added the above solution A at -20 to -15C and stirred at that temperature for 40 minutes. The resultant solution was poured into a solution of saturated aqueous sodium bicarbonate (30 ml) and water (40 ml) with ice cooling. The aqueous layer was separated, washed with ethyl acetate, and then ethyl acetate (50 ml) was added to the aqueous layer and adjusted to pH 3 with 10% hydrochloric acid. The organic layer was separated and extracted with ethyl acetate twice. The extracts were combined, washed with water and concentrated to a small volume. The resulting precipitates were collected by filtration, washed with ethyl acetate and dried, to give the acylated compounds in 40-70 % yield.
(2) Conc hydrochloric acid (0.4 ml) was added to a solution of the above product (Z isomer, 2 mmol) in methanol (15 nil) and stirred at room temperature for 40 minutes. After the methanol removed, water (100 ml) was added to the residue, which was then dissolved by adding 10 % hydrochloric acid. After some insoluble material was filtered off, the filtrate was adjusted to pH 3 with aqueous sodium bicarbonate and then submitted to column chromatography on macroporous, non-ionic adsorption resin (Diaion HP-20), with an eluant of aqueous methanol. The eluate was lyophilized to give the desired cephalosporins (40 -65 %). B) Synthesis of Cephalosporins 19, 20 (Z isomer): A solution of 7-[2-(2-formamidopyridin-6-yl)-2-methoxyiminoacetamido]cephalosporanic acid (Z isomer) (5 mmol) and disodium 2-(5-mercaptolH-tetrazol-1-yl)acetate (6 mmol) in water (40 nil) was adjusted to pH 7 with sodium bicarbonate, and stirred at 65°C for 6 hours at pH 7 to 7.4. The resultant solution was washed with ethyl acetate, adjusted to pH 2.5 with 10% hydrochloric acid and stirred. The precipitates were collected by filtration, washed with water and diethyl ether to give 7-[2-(2-formamidopyridin-6-yl)-2-methoxyiminoacetamido]-3-[(1-carboxymethyl-I H-tetrazol-5-yl)thiomethyl]-3-cephem-4-carboxylic acid (Z isomer) (1.3 g, 44.0 %); 
